Funding News: 30 July 2010
July 30, 2010
In This Issue:
-
* Student and institutional support programs
-
* GrantsNet sponsorship
New Research Funding Programs
- American Kidney Fund
-
Clinical Scientist in Nephrology (CSN) Program
The American Kidney Fund is pleased to invite applications for its Clinical Scientist in Nephrology (CSN) Program for the academic year 2011–12. The goal of the CSN Program is to improve the quality of care provided to kidney patients and to promote clinical research in nephrology. This goal is achieved by enhancing the training of nephrologists who desire to pursue academic careers and whose primary professional commitment is to scholarship in the provision of patient care. Awardees conduct prevention and outcomes research while receiving advanced training in essential skills such as medical ethics, biostatistics, and epidemiology. A Clinical Scientist in Nephrology fellowship may be granted yearly. The maximum duration of each fellowship is 2 years. The maximum level of funding is $80,000 per year and shall be used principally to support the candidate and his/her career development. This sum is expected to cover the individual fellow's salary. Applications are due by 1 December. Deadline: 2010-12-01
- Department of Agriculture. National Institute of Food and Agriculture
-
Critical Issues: Emerging and New Plant and Animal Diseases
This program is designed to provide one-time seed funding to help initiate work requiring immediate attention until other longer-term resources can be secured to address the issue. The National Institute of Food and Agriculture (NIFA) will be soliciting proposals on an as-needed basis during the year to address specific new or emerging issues. For this particular solicitation, NIFA is requesting proposals that address specific aspects of the following animal pest and disease issue: development and dissemination of new knowledge supporting radiological incident preparedness, response, and recovery for U.S. animal agriculture, and animal-derived food production infrastructures. Priority will be given to proposals that demonstrate evidence of collaboration and communication with working groups and approved multistate research committees, however, all applicants qualified to conduct the research are encouraged to apply. Approximately $318,600 is available to fund applications in fiscal year 2010. Deadline: 2010-08-16
- Department of Health and Human Services. National Institutes of Health
-
Epigenomic Modifications in Neurodevelopment (R21)
This funding opportunity announcement (FOA) issued by the National Institute of Mental Health (NIMH), National Institutes of Health (NIH), solicits research grant applications that characterize epigenetic events involved in neurodevelopmental processes or propose to identify epigenome-wide marks associated with early environmental influences and vulnerability to mental disorders. Studies that provide cross-species analysis and/or studies that address heterogeneity of epigenetic marks across tissue types, including cell specificity in the brain across development, are of particular interest. This FOA will utilize the NIH Exploratory/Developmental Research Grant (R21) award mechanism and runs in parallel with an FOA of identical scientific scope, RFA-MH-11-030, that solicits applications utilizing the research project grant (R01) award mechanism. NIMH intends to commit approximately $5 million in total costs in fiscal year 2011 to fund 10 or more R01 and R21 awards in response to this FOA and the companion announcement. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Deadline: 2010-09-20; 2010-10-20
- Department of Health and Human Services. National Institutes of Health
-
Epigenomic Modifications in Neurodevelopment (R01)
This funding opportunity announcement (FOA) issued by the National Institute of Mental Health (NIMH), National Institutes of Health (NIH), solicits research grant applications that characterize epigenetic events involved in neurodevelopmental processes or propose to identify epigenome-wide marks associated with early environmental influences and vulnerability to mental disorders. Studies that provide cross-species analysis and/or studies that address heterogeneity of epigenetic marks across tissue types, including cell specificity in the brain across development, are of particular interest. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, RFA-MH-11-031, that solicits applications utilizing the Exploratory/Developmental (R21) award mechanism. NIMH intends to commit approximately $5 million in total costs in fiscal year 2011 to fund 10 or more R01 and R21 awards in response to this FOA and the companion announcement. Deadline: 2010-09-20; 2010-10-20
- Department of Health and Human Services. National Institutes of Health
-
The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Coordinating Center (U01)
The purpose of this funding opportunity announcement (FOA) is to support a coordinating center to serve as a centralized resource to facilitate and support the Electronic Medical Records and Genomics Network, phase II, to incorporate state-of-the-art methods generated in eMERGE phase I into clinical research and ongoing clinical care in a phase II eMERGE expansion. This FOA will utilize the U01 Cooperative Agreement award mechanism. The total amount of funding to be awarded through this FOA is $3.5 million. It is anticipated that one award will be made under this FOA. Deadline: 2010-10-17; 2010-11-17
- Department of Health and Human Services. National Institutes of Health
-
The Electronic Medical Records and Genomics (eMERGE) Network, Phase II Study Investigators (U01)
The purpose of this funding opportunity announcement (FOA) is to provide support for the most competitive existing Electronic Medical Records and Genomics phase I sites and new sites with existing biorepositories and genomewide genotyping data to incorporate state-of-the-art methods generated in eMERGE phase I into clinical research and ongoing clinical care in a phase II eMERGE expansion. This FOA will utilize the U01 Cooperative Agreement award mechanism. The total amount to be awarded over the 4-year period of this FOA is approximately $22 million. It is anticipated that up to eight awards will be made under this FOA. Deadline: 2010-10-17; 2010-11-17
- Department of Health and Human Services. National Institutes of Health
-
Community Clinical Oncology Program Groups (U10)
This funding opportunity announcement (FOA) solicits applications from institutions/organizations that propose to serve as research groups for the National Cancer Institute (NCI)–supported Community Clinical Oncology Program (CCOP) Network. CCOP was established in 1983 to develop and conduct state-of-the-art cancer prevention, control, and treatment clinical trials with significant involvement of community oncologists and populations they serve. The CCOP Network mission includes: (1) accelerating development of interventions to prevent and treat cancer and its symptoms by increasing accrual to trials; (2) fostering quality care in the community through adoption of results from clinical trials; and (3) increasing the involvement of minority and underserved patient/participant populations in cancer clinical trials and associated research. A CCOP Group encompasses community oncologists who accrue patients/participants to NCI-approved clinical trials. The Minority-Based Community Clinical Oncology Programs (MBCCOPs) are formed by oncologists in communities with a high proportion of minority patients and that accrue patients/participants to NCI-approved clinical trials. These trials are designed and conducted by CCOP Research Bases, which also manage and analyze the data and report the results. CCOP Research Bases must be located either at an NCI-supported Clinical Cooperative Group or at an NCI-designated Cancer Center. This FOA will utilize the National Institutes of Health U10 cooperative agreement award mechanism. Parallel FOAs (RFA-CA-10-011 and RFA-CA-10-012) solicit applications for CCOP Research Bases and MBCCOP Groups respectively. It is imperative that CCOP Group applicants familiarize themselves with these parallel FOAs. NCI intends to commit up to $1.8 million in total costs in fiscal year 2011 to fund approximately three CCOP Group awards. Deadline: 2010-08-16; 2010-09-16
- Department of Health and Human Services. National Institutes of Health
-
Community Clinical Oncology Program Research Bases (U10)
This funding opportunity announcement (FOA) solicits applications from institutions/organizations that propose to serve as research bases for the National Cancer Institute (NCI)–supported Community Clinical Oncology Program (CCOP) Network. The goal for CCOP is to develop and conduct state-of-the-art cancer prevention, control, and treatment clinical trials with significant involvement of community oncologists and populations they serve. The CCOP Network consists of three components (each with its own FOA), which are: CCOP Groups (also referred to as CCOPs); Minority-Based Community Clinical Oncology Program (MBCCOPs); and CCOP Research Bases (covered by this FOA). A CCOP Group encompasses community oncologists who accrue patients/participants to NCI-approved clinical trials. MBCCOPs are formed by oncologists in communities with a high proportion of minority patients that accrue patients/participants to NCI-approved clinical trials. These trials are designed and conducted by CCOP Research Bases, which also manage and analyze the data and report the results. CCOP Research Bases must be located either at an NCI-supported Clinical Cooperative Group or at an NCI-designated Cancer Center. This FOA will utilize the NIH U10 cooperative agreement award mechanism. Parallel FOAs (RFA-CA-10-010 and RFA-CA-10-012) solicit applications for CCOP Groups and MBCCOP Groups respectively. It is imperative that CCOP Research Base applicants familiarize themselves with these parallel FOAs for groups. NCI intends to commit up to $1.5 million in total costs in fiscal year 2011 to fund one CCOP Research Base award. Deadline: 2010-08-16; 2010-09-16
- Department of Health and Human Services. National Institutes of Health
-
Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (SBIR [R43])
This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small-business concerns to (1) propose research, (2) develop new devices and instruments, and/or (3) improve existing devices and instruments to monitor and treat newborn infants and small children safely and efficaciously. This FOA will utilize the SBIR (R43) grant mechanism for phase I applications and runs in parallel with an FOA of identical scientific scope, RFA-HD-10-013, that solicits applications under the Small Business Technology Transfer (R41) grant mechanism. This FOA does not support SBIR phase II, Fast-Track, or phase II Competing Renewal applications. The National Institute of Child Health and Human Development has set aside $900,000 to support up to four meritorious applications; the National Heart, Lung and Blood Institute has set aside $900,000 to support up to four meritorious applications; and the National Institute on Deafness and Other Communication Disorders has set aside $225,000 to support one meritorious application for the fiscal year 2011. Future year amounts will depend on annual appropriations. Deadline: 2010-08-17; 2010-09-17
- Department of Health and Human Services. National Institutes of Health
-
Minority-Based Community Clinical Oncology Program Groups (U10)
This funding opportunity announcement (FOA) solicits applications for the program known as the Minority-Based Community Clinical Oncology Program (Minority-Based CCOP). This program allows practicing oncologists who serve large minority populations to participate in National Cancer Institute (NCI)–sponsored clinical trials. The purpose of this program is to support, as a national resource, research activities of physicians involved in the care of minorities who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials. The NCI clinical trials program supports CCOPs by providing access to clinical trials in cancer centers, major university centers, and community programs. The linkage of minority cancer patients/participants to the current clinical trials network facilitates the transfer of new research advancements in cancer prevention/control/treatment practices to minority communities and their physicians. The CCOP Network consists of three components each with its own FOA. The components are as follows: Minority Based-CCOPs (covered by this FOA), CCOP Groups (also referred to as CCOPs), and CCOP Research Bases. CCOP Research Bases must be located either at an NCI-supported Clinical Cooperative Group or at an NCI-designated Cancer Center. CCOP was established in 1983 to develop and conduct state-of-the-art cancer prevention, control, and treatment clinical trials with significant involvement of community oncologists and populations they serve. The CCOP Network mission includes: (1) accelerating development of interventions to prevent and treat cancer and its symptoms by increasing accrual to trials; (2) fostering quality care in the community through adoption of results from clinical trials; and (3) increasing the involvement of minority and underserved patient/participant populations in cancer clinical trials and associated research. This FOA will utilize the National Institutes of Health U10 cooperative agreement award mechanism. Parallel FOAs (RFA-CA-10-010 and RFA-CA-10-011) solicit applications for Minority-Based CCOPs and CCOP Research Bases, respectively. It is imperative that Minority-Based CCOP applicants familiarize themselves with these parallel FOAs. NCI intends to commit up to $2 million in total costs in fiscal year 2011 to fund approximately five Minority-Based CCOP awards. Deadline: 2010-08-16; 2010-09-16
- Department of Health and Human Services. National Institutes of Health
-
Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR [R41])
This funding opportunity announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small-business concerns to propose research to develop new devices and instruments, and/or improve existing devices and instruments, to monitor and treat newborn infants and small children safely and efficaciously. This FOA will utilize the STTR (R41) grant mechanism for phase I applications and runs in parallel with an FOA of identical scientific scope, RFA-HD-10-012, that solicits applications under the Small Business Innovative Research (R43) grant mechanism. This FOA does not support STTR phase II, Fast-Track, or phase II Competing Renewal applications. The Eunice Kennedy Shriver National Institute of Child Health and Human Development has set aside $450,000 to support up to two meritorious applications; and the National Heart, Lung and Blood Institute has set aside $450,000 to support up to two meritorious applications for the fiscal year 2011. Future year amounts will depend on annual appropriations. Deadline: 2010-08-17; 2010-09-17
- Department of Health and Human Services. National Institutes of Health
-
Pediatric Heart Network Clinical Centers (U10)
The primary objective of this funding opportunity announcement (FOA) is to support the Clinical Centers in the Pediatric Heart Network (PHN). The mission of PHN is to improve the health and quality of life for children, adolescents, and young adults with congenital and acquired heart disease through multicenter collaborative clinical research. PHN provides an infrastructure to permit multicenter evaluation of medical, interventional, and surgical therapies; to serve as a training platform for fellows, junior faculty members and nurses; and to disseminate results of studies to improve the scientific basis for the care of affected individuals. There is a separate FOA for the PHN Data Coordinating Center (RFA-HL-11-027). This FOA will utilize the U10 grant mechanism. NHLBI expects to award approximately $64.420 million total costs over 5 years through this announcement. The anticipated number of awards will support up to eight clinical sites and one data-coordinating center. The maximum annual amount for each clinical center will be $300,000 direct costs per year for 5 years. Patient-care funds vary with each funding year but are awarded to the data-coordinating center for all network studies. Deadline: 2010-09-29; 2010-10-29
- Department of Health and Human Services. National Institutes of Health
-
Innovative Therapies and Tools for Screenable Disorders in Newborns (R01)
This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the National Institute on Deafness and Other Communication Disorders encourages Research Project Grant (R01) applications from institutions/organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high-priority genetic conditions for which screening could be possible in the near future. In this FOA, a high-priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening. This FOA will utilize the R01 funding mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-10-231 and PAR-10-232, that encourage applications under the R03 and R21 mechanisms. Deadline: 2010-10-05; 2011-02-05; 2011-06-05
- Department of Health and Human Services. National Institutes of Health
-
Innovative Therapies and Tools for Screenable Disorders in Newborns (R03)
This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development encourages small research project grant (R03) applications from institutions/organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high-priority genetic conditions for which screening could be possible in the near future. In this FOA, a high-priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This FOA will utilize the National Institutes of Health Small Research Grant (R03) award mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-10-230 and PAR-10-232, that encourage applications under the R01, R21 mechanisms. Budgets for direct costs of up to $50,000 per year and a project duration of up to 2 years may be requested for a maximum of $100,000 direct costs over a 2-year project period. Deadline: 2010-10-16; 2011-02-16; 2011-06-16
- National Science Foundation
-
Research and Evaluation on Education in Science and Engineering
The Research and Evaluation on Education in Science and Engineering (REESE) program seeks to advance research at the frontiers of science, technology, engineering, and mathematics (STEM) learning, education, and evaluation. The program also seeks to provide the foundational knowledge necessary to improve STEM teaching and learning at all educational levels and in all settings. This solicitation calls for four types of proposals--pathways, synthesis, empirical research, and large empirical research. The goals of the REESE program are to: (1) catalyze discovery and innovation at the frontiers of STEM learning, education, and evaluation; (2) stimulate the field to produce high-quality and robust research results through the progress of theory, method, and human resources; and (3) coordinate and transform advances in education, learning research, and evaluation. REESE places particular importance upon the involvement of young investigators in the projects at doctoral, postdoctoral, and early-career stages, as well as the involvement of STEM disciplinary experts. In addition, research questions related to educational research methodology and evaluation are central to the REESE activity. The estimated number of awards is 23 to 40. The anticipated funding amount is $29 million. Deadline: 2010-11-15
- National Science Foundation
-
Centers for Chemical Innovation
The Centers for Chemical Innovation (CCI) Program supports research centers focused on major, long-term, fundamental chemical research challenges. CCIs that address these challenges will (1) produce transformative research, (2) lead to innovation, and (3) attract broad scientific and public interest. CCIs are agile structures that can respond rapidly to emerging opportunities and make full use of cyberinfrastructure to enhance collaborations. CCIs may partner with researchers from industry, government laboratories, and international organizations. CCIs integrate research, innovation, education, and public outreach and include a plan to broaden participation of underrepresented groups. The CCI program is a two-phase program. Both phases are described in this solicitation. Phase I CCIs receive significant resources to develop the science and integrative elements of a CCI before requesting phase II funding. Phase I proposals funded in fiscal year 2011 will seek phase II funding in FY 2014. Only organizations receiving phase I awards in FY 2008 are eligible to request phase II funding in FY 2011. In FY 2011, three or four phase I awards and one or two phase II awards. The anticipated funding amount is $7 million to $12 million in FY 2011. Deadline: 2010-10-12
GrantsNet Express
GrantsNet Express offers a new listing each week by e-mail of science funding opportunities from private foundations and organizations, as well as new U.S. government science grant announcements.
New Student and Institutional Support Programs
- Department of Health and Human Services. National Institutes of Health
-
Informatics, Coordination and Service Center for the Mutant Mouse Regional Resource Centers (U42)
The goal of this funding opportunity announcement (FOA) issued by the National Center for Research Resources, National Institutes of Health, is to solicit applications from institutions/organizations to establish and further develop and implement the Informatics, Coordination and Service Center (ICSC) component of the Mutant Mouse Regional Resource Center (MMRRC) program. This ICSC component will replace the functions of the contract-supported mutant mouse informatics coordinating center at the Jackson Laboratory in Bar Harbor, Maine. That center is expected to close 31 August. The newly established ICSC is expected to provide informatics and coordinating services to the centers of MMRRC and biomedical researchers. These services include maintenance and further development of a public Web site portal and customer service center, to facilitate interactions with biomedical investigators, informatics services, database activities, an archive of MMRRC documents and files, and coordination of requests to donate mouse strains to MMRRC and order mouse strains from MMRRC. Moreover, ICSC will actively participate in the monthly teleconference and annual consortium meeting and coordinate the acquisition and distribution of strains. This FOA will utilize the U42 Cooperative Agreement (Animal Models, and Animal and Biological Material Resource Cooperative Agreement) grant mechanism. A total of up to $650,000 in direct cost is available, contingent on the availability of funds. It is anticipated that one new award will be made contingent on the availability of funds and the submission of meritorious applications. Deadline: 2010-10-07
- Department of Health and Human Services. National Institutes of Health
-
Clinical and Translational Science Coordinating Center (U54)
The purpose of this funding opportunity announcement (FOA) is to solicit applications for a Clinical and Translational Science Coordinating Center. CTSCC will encourage and facilitate collaboration, sharing, and interaction within the Clinical and Translational Science Awards (CTSA) consortium and with the consortium of non-CTSA institutions, organizations, and programs also focused on advancing the efficiency and quality of clinical and translational research and training. CTSCC will also facilitate the communication of the results of these collaborations to others. CTSCC will provide a Web site for collaboration including wikis, forums, and public and private work spaces to facilitate the communal development and adoption of best practices for conduct of clinical and translational research to enhance quality, efficiency, and value. Please read the full announcement for more information. This FOA will utilize the U54 award mechanism. National Center for Research Resources expects to fund one application for approximately $4 million in fiscal year 2012. The total project period for an application submitted in response to this funding opportunity may not exceed 5 years. Total costs for the 5 years may not exceed $20 million total costs. Deadline: 2010-12-15; 2011-01-12
[ top ]
Deadline Watch
(Image: comstock)
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-02; 2010-09-01
- Society for Imaging Informatics in Medicine (SIIM)
-
Deadline: 2010-08-02
- Society for Imaging Informatics in Medicine (SIIM)
-
2011 Small Grant for Imaging Informatics Training
Deadline: 2010-08-02
- Council for International Exchange of Scholars
-
Fulbright Postdoctoral Research in Israel
Deadline: 2010-08-02
- Department of Health and Human Services . National Institutes of Health
-
MAPGen Knowledge Base (MAPGenKB) and Coordination Center (U01)
Deadline: 2010-08-02; 2010-09-01
- Alex's Lemonade Stand Foundation
-
Deadline: 2010-08-02
- Department of Health and Human Services. National Institutes of Health
-
New Strategies for Growing 3D Tissues (R01)
Deadline: 2010-08-02; 2010-09-01
- Department of Health and Human Services. National Institutes of Health
-
New Strategies for Growing 3D Tissues (R21)
Deadline: 2010-08-02; 2010-09-01
- National Aeronautics and Space Administration. NASA Headquarters
-
Deadline: 2010-08-03; 2010-09-03
- National Science Foundation
-
Science, Technology, Engineering, and Mathematics Talent Expansion Program Centers
Deadline: 2010-08-04; 2010-09-07
- Department of Health and Human Services. National Institutes of Health
-
NIAID Advanced Technology STTR (NIAID-AT-STTR [R41/R42])
Deadline: 2010-08-05; 2010-12-05; 2011-04-05
- Department of Health and Human Services. National Institutes of Health
-
Bioengineering Nanotechnology Initiative (SBIR [R43/R44])
Deadline: 2010-08-05; 2010-12-05; 2011-04-05
- Department of Health and Human Services. National Institutes of Health
-
Bioengineering Nanotechnology Initiative (STTR [R41/R42])
Deadline: 2010-08-05; 2010-12-05; 2011-04-05
- Department of Health and Human Services. National Institutes of Health
-
Advanced Tools and Technologies for Deep Brain Stimulation (SBIR [R43/R44])
Deadline: 2010-08-05; 2010-12-05; 2011-04-05
- Department of Health and Human Services. National Institutes of Health
-
Advanced Tools and Technologies for Deep Brain Stimulation (STTR [R41/R42])
Deadline: 2010-08-05; 2010-12-05; 2011-04-05
- National Aeronautics and Space Administration. NASA Headquarters
-
Nasa Astrobiology Institute Minority Institution Research Support - MIRS Program
Deadline: 2010-08-06; 2010-10-07
- Department of Health and Human Services. National Institutes of Health
-
Novel NeuroAIDS Therapeutics: Integrated Preclinical/Clinical Program (P01)
Deadline: 2010-08-07; 2010-09-07; 2011-08-07; 2011-09-07
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-08; 2010-12-08; 2011-04-08
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-08; 2010-12-08; 2011-04-08
- Department of Health and Human Services. National Institutes of Health
-
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31)
Deadline: 2010-08-08; 2010-12-08; 2011-04-08
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-08; 2010-12-08; 2011-04-08
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-08; 2010-12-08; 2011-04-08
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-08; 2010-12-08; 2011-04-08
- Department of Health and Human Services. National Institutes of Health
-
SBIR E-learning for HAZMAT and Emergency Response (SBIR [R43/R44])
Deadline: 2010-08-08; 2010-09-08
- Department of Health and Human Services. National Institutes of Health
-
NIDA Research Education Program for Clinical Researchers and Clinicians (R25)
Deadline: 2010-08-09; 2010-09-07
- Department of Education
-
Deadline: 2010-08-10
- Department of Education
-
Deadline: 2010-08-10
- National Science Foundation
-
Deadline: 2010-08-11; 2011-01-25
- Mesothelioma Applied Research Foundation, Inc.
-
Deadline: 2010-08-11
- Department of Health and Human Services. National Institutes of Health
-
Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R01)
Deadline: 2010-08-14; 2010-09-14; 2010-12-11; 2011-01-11
- Department of Health and Human Services. National Institutes of Health
-
Behavioral and Social Science Research on Understanding and Reducing Health Disparities (R21)
Deadline: 2010-08-14; 2010-09-14; 2010-12-11; 2011-01-11
- Department of Health and Human Services. National Institutes of Health
-
Countermeasures Against Chemical Threats (CounterACT) Cooperative Research Projects (U01)
Deadline: 2010-08-14; 2010-09-14; 2011-08-14; 2011-09-14
- Department of Health and Human Services. National Institutes of Health
-
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)
Deadline: 2010-08-14; 2010-09-14; 2011-08-14; 2011-09-14
- Damon Runyon Cancer Research Foundation
-
Damon Runyon Postdoctoral Fellowship
Deadline: 2010-08-16; 2011-03-15; 2011-08-15; 2012-03-15
- Department of Health and Human Services . National Institutes of Health
-
Planning Grants for Pivotal Clinical Trials in Hemoglobinopathies (R34)
Deadline: 2010-08-16; 2010-09-14
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-16; 2010-09-15
- Department of Health and Human Services. Administration for Children and Families
-
National Autism Resource and Information Center
Deadline: 2010-08-16
- Department of Health and Human Services. National Institutes of Health
-
Community Clinical Oncology Program Groups (U10)
Deadline: 2010-08-16; 2010-09-16
- Department of Health and Human Services. National Institutes of Health
-
Community Clinical Oncology Program Research Bases (U10)
Deadline: 2010-08-16; 2010-09-16
- Department of Agriculture. National Institute of Food and Agriculture
-
Critical Issues: Emerging and New Plant and Animal Diseases
Deadline: 2010-08-16
- Department of Health and Human Services. National Institutes of Health
-
Minority-Based Community Clinical Oncology Program Groups (U10)
Deadline: 2010-08-16; 2010-09-16
- Department of Health and Human Services. National Institutes of Health
-
Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (SBIR [R43])
Deadline: 2010-08-17; 2010-09-17
- Department of Health and Human Services. National Institutes of Health
-
Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR [R41])
Deadline: 2010-08-17; 2010-09-17
- Foundation for Physical Therapy
-
Deadline: 2010-08-18
- National Science Foundation
-
Research Coordination Networks (RCN)
Deadline: 2010-08-18; 2011-07-05; 2012-07-02
- Department of Health and Human Services. National Institutes of Health
-
Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R01)
Deadline: 2010-08-20; 2010-09-21; 2011-08-20; 2011-09-21
- Department of Health and Human Services. National Institutes of Health
-
Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R03)
Deadline: 2010-08-20; 2010-09-21; 2011-08-20; 2011-09-21
- Department of Health and Human Services. National Institutes of Health
-
Vulvodynia - Systematic Epidemiologic, Etiologic or Therapeutic Studies (R21)
Deadline: 2010-08-20; 2010-09-21; 2011-08-20; 2011-09-21
- Department of Health and Human Services. National Institutes of Health
-
Biophysical and Biomechanical Aspects of Embryonic Development (R01)
Deadline: 2010-08-20; 2010-09-20; 2011-08-20; 2011-09-20
- Department of Health and Human Services. National Institutes of Health
-
Biophysical and Biomechanical Aspects of Embryonic Development (R21)
Deadline: 2010-08-20; 2010-09-20; 2011-08-20; 2011-09-20
- Department of Health and Human Services. National Institutes of Health
-
Development and Translation of Medical Technologies that Reduce Health Disparities (SBIR [R43/R44])
Deadline: 2010-08-22; 2010-09-22
- National Science Foundation
-
Advances in Biological Informatics
Deadline: 2010-08-23; 2011-07-12
- Department of Defense . Defense Advanced Research Projects Agency
-
PROgramming Computation on EncrytEd Data
Deadline: 2010-08-24; 2011-01-03
- Department of Health and Human Services. National Institutes of Health
-
Institutional Training for a Dental and Craniofacial Research Workforce (T90/R90)
Deadline: 2010-08-25; 2010-09-25; 2011-08-25; 2011-09-25
- Department of Health and Human Services. National Institutes of Health
-
NIDA Research "Center of Excellence" Grant Program (P50)
Deadline: 2010-08-25; 2010-09-25; 2011-08-25; 2011-09-25
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-08-25; 2010-09-25; 2011-08-25; 2011-09-25
- South Moravian Centre for International Mobility
-
Deadline: 2010-08-25
- South Moravian Centre for International Mobility
-
Deadline: 2010-08-25
- Alzheimer's Drug Discovery Foundation
-
Novel Biomarkers to Accelerate Drug Discovery for Frontotemporal Dementias
Deadline: 2010-08-26; 2010-09-09
- Human Frontier Science Program Organization
-
Cross-Disciplinary Fellowships
Deadline: 2010-08-26; 2010-09-09
- Human Frontier Science Program Organization
-
Deadline: 2010-08-26; 2010-09-09
- National Science Foundation
-
Instrument Development for Biological Research
Deadline: 2010-08-27; 2011-07-29
- The New York Stem Cell Foundation
-
Innovator Awards Program for Early Career Investigators
Deadline: 2010-08-27
GrantsNet Sponsorship
Sponsorship opportunities are now available on GrantsNet and GrantsNet Express. Please contact Tracy Holmes for more information.
[ top ]
Donisha Adams is the GrantsNet Program Associate. | |
10.1126/science.caredit.f20100730 |
